Navigation Links
Concomitant treatment with nebulized formoterol fumarate & tio-significant improvements -- COPD
Date:5/20/2008

formoterol fumarate. Formoterol fumarate is a rapid and long-acting beta2-agonist (LABA) that has been previously available in the U.S. in a dry powder formulation with twenty years of worldwide experience. Nebulizers convert liquid medication into a mist that patients inhale through a mouthpiece or facemask.

Taken together, these studies expand our understanding of the clinical benefits of Perforomist Inhalation Solution for the treatment of COPD, said Carolyn Myers, Ph.D., President of Dey, L.P. Perforomist Inhalation Solution offers physicians a flexible, safe, and highly effective treatment option for COPD -- and many patients may benefit from this new addition to the treatment armamentarium.


'/>"/>

Contact: Amy Techtmann
amy.techtmann@fkhealth.com
617-761-6784
Feinstein Kean Healthcare
Source:Eurekalert

Page: 1 2 3 4

Related medicine news :

1. Clinical trial data: Safety/efficacy of concomitant formoterol fumarate/tiotropium treating COPD
2. New treatment effective in counteracting cocaine-induced symptoms
3. New treatment boosts muscle function in myasthenia gravis
4. Broad-based group of physicians calls for improvement in stroke treatment
5. Cranberry Could Juice Up Ovarian Cancer Treatment
6. Non-medicinal treatment touted for pre-schoolers with ADHD
7. Nonmedicinal treatment touted for preschoolers with ADHD
8. U of M study: Early treatment can reverse heart damage
9. Biologic treatment for rheumatoid arthritis and the risk of cancer
10. New Treatment Explored for Cluster Headaches
11. Thailand: Partners Open Free AIDS Treatment Clinic in Renowned AIDS Temple in Lop Buri
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/22/2014)... Physicians in China are most eagerly awaiting a ... lymphoma (NHL), according to a new report from ... MabThera is the only biologic available to treat diffuse ... NHL. , According to Kantar Health’s report, “Biosimilars in ... in China has been growing and is expected to ...
(Date:12/22/2014)... Super Saturday, the last Saturday before ... the busiest day in the 2014 holiday shopping season. ... had a steady pre-Christmas stream of customers, ready to ... , “I definitely intend to take advantage…of the recreational ... who was enjoying The Grass Station’s holiday sale on ...
(Date:12/22/2014)... 22, 2014 Only weeks following the ... mid-western cities to have a battery manufacturer create 29 ... ( http://www.talklocal.com ) is launching in Henderson to ... , “A strong manufacturing sector is going to build ... Singh explained, “and TalkLocal works with small businesses that ...
(Date:12/22/2014)... In recognition of Veteran’s Day, Discount Labels ... a local organization that provides services to veterans and ... on a couple hundred acres in the hills of ... class fishing, hunting, hiking, horseback riding, 4-wheeling, skeet shooting, ... ago to support U.S. Service men and women, police ...
(Date:12/22/2014)... (PRWEB) December 22, 2014 Pasadena ... offering consultations for sleep apnea. Drowsy drivers are 15 ... drivers who are well-rested, and some experts believe that ... roads as intoxicated drivers. Unfortunately, millions of Americans may ... American Academy of Sleep Medicine, about 18 million Americans ...
Breaking Medicine News(10 mins):Health News:Physicians in China See Most Significant Demand for MabThera Biosimilar 2Health News:Physicians in China See Most Significant Demand for MabThera Biosimilar 3Health News:Customers at Colorado’s Grass Station Say They’re Enjoying the Experience of Legally Purchasing Marijuana this Year to Give as Christmas Presents to Friends and Family 2Health News:TalkLocal Launches in Henderson Weeks Following New Megafactory, New Jobs Announcement 2Health News:Discount Labels Donates Portion of November Sales to Hero Reward Program 2Health News:Pasadena Dentist, Dr. Marine Martirosyan, Now Offers Consultations for Sleep Apnea 2
... adolescents and young adults finds that an extensive set ... of asthma attacks in participants who both receive care ... This finding differs from previous reports suggesting that ... future asthma attacks. These earlier conclusions, however, were based ...
... of blocking the formation of specific protein clumps that ... been discovered by researchers at the University of Pennsylvania ... they have identified drug-like inhibitors of AD tau protein ... Co-authors Alex Crowe, Research Specialist; Kurt R. ...
... , , Campaign couples power ... , HARRISBURG, Pa., Aug. 10 /PRNewswire-USNewswire/ -- ... Health Action Now campaign with a multimillion-dollar national advertising and grassroots ... dependable, affordable health insurance. The Association,s paid advertising -- available ...
... , PITTSBURGH, Aug. 10 DynaVox Mayer-Johnson, ... for individuals with speech, language and learning disabilities, today ... standard for hand-held speech solutions by bringing together comprehensive ... of mainstream communication features. , , ...
... other contact sports, study finds , MONDAY, Aug. 10 (HealthDay ... about the same rate as in baseball and football, deaths ... common in lacrosse, new research shows. , Lacrosse has swept ... making it the fastest-growing youth sport in the country. The ...
... , , HUDSON, Mass., Aug. 10 ... provider of high performance interconnect solutions for the most ... series circular connectors were selected by SynCardia Systems, Inc. ... to provide critical interconnect reliability for their Freedom(TM) driver, ...
Cached Medicine News:Health News:NIAID media availability: Still searching for predictors of asthma attacks 2Health News:New class of compounds discovered for potential Alzheimer's disease drug 2Health News:New class of compounds discovered for potential Alzheimer's disease drug 3Health News:Multimillion-Dollar AARP Campaign Busts the Myths of the Health Care Debate 2Health News:Multimillion-Dollar AARP Campaign Busts the Myths of the Health Care Debate 3Health News:DynaVox Mayer-Johnson Announces the Xpress 2Health News:DynaVox Mayer-Johnson Announces the Xpress 3Health News:Blows to the Chest Up Death Risk for Lacrosse Players 2Health News:Blows to the Chest Up Death Risk for Lacrosse Players 3Health News:Hypertronics HyperGrip(R) and D Series Connectors Selected for SynCardia's Total Artificial Heart 2
(Date:12/22/2014)... VIEJO, Calif. , Dec. 22, 2014 ... into expanded corporate offices in Aliso Viejo ... announced that due to the tremendous growth and worldwide ... needed. Sales of patented SnoreRx, the anti snore cure ... offices. He said, "We are now in 23 ...
(Date:12/22/2014)... a privately-held medical products and technologies company, today announced ... Officer of the company, effective December 22, 2014. ... Board of Directors of ConvaTec thanks Mr. Berger for ... years," said Magnus Lundberg , the Chairman of ... company is well positioned for the future."  The company ...
(Date:12/22/2014)... 2014  Mark Farrah Associates (MFA), www.markfarrah.com ... of the 2015 marketplace exchange projections and insights ... According to a recent ASPE (Office of ... of Health and Human Services) report, an estimated ... plans through the Marketplace as of October 2014 ...
Breaking Medicine Technology:ConvaTec Names Paul Moraviec Interim CEO Effective December 22, 2014 2Insights into the Marketplace and Individual Market Growth 2
... Switzerland, June 20, Actelion Ltd (SWX: ATLN) announced ... in mildly symptomatic pulmonary,arterial hypertension (PAH) patients (WHO ... prevented clinical deterioration by significantly,delaying time to clinical ... WHO FC III/IV. A significant reduction in pulmonary ...
... Inc.,(Nasdaq: TRBN ) today announced that Wyeth ... has exercised its option under the terms of ... period for an,additional one-year period through Dec. 22, ... Wyeth,s obligations to Trubion include,collaboration research funding commitments ...
Cached Medicine Technology:Pivotal Pulmonary Arterial Hypertension Study Published in The Lancet Concludes That Bosentan (Tracleer(R)) Demonstrates Benefits in Patients With Mildly Symptomatic WHO Functional Class II Disease 2Pivotal Pulmonary Arterial Hypertension Study Published in The Lancet Concludes That Bosentan (Tracleer(R)) Demonstrates Benefits in Patients With Mildly Symptomatic WHO Functional Class II Disease 3Pivotal Pulmonary Arterial Hypertension Study Published in The Lancet Concludes That Bosentan (Tracleer(R)) Demonstrates Benefits in Patients With Mildly Symptomatic WHO Functional Class II Disease 4Pivotal Pulmonary Arterial Hypertension Study Published in The Lancet Concludes That Bosentan (Tracleer(R)) Demonstrates Benefits in Patients With Mildly Symptomatic WHO Functional Class II Disease 5Pivotal Pulmonary Arterial Hypertension Study Published in The Lancet Concludes That Bosentan (Tracleer(R)) Demonstrates Benefits in Patients With Mildly Symptomatic WHO Functional Class II Disease 6Trubion Pharmaceuticals Announces Extension of Research Period Under Its Wyeth Collaboration 2Trubion Pharmaceuticals Announces Extension of Research Period Under Its Wyeth Collaboration 3
Research Series 2100 Adjustable-volume Pipette,100-1,000 l, single-channel with adjustable-volume setting...
... first Sysmex hematology analyzer designed for a ... its small footprint, closed tube sampling, and ... of whole blood sample, you have a ... the emergency room, surgical suite, or small ...
... The Integrity family of pacemakers ... and truly automatic devices in today's ... combination of automated features and diagnostic ... popular and proven Affinity pacemakers platform. ...
... PT System is an in vitro diagnostic ... results, expressed in seconds and INR units. ... It is intended for use by health ... to monitor patients who are on warfarin-type ...
Medicine Products: